KR950703360A - 미코박테리아 바케로부터의 치료제 및 hiv감염에 대한 그의 사용(therapeutic agent from mycobacterrium vaccae and its use against hiv infection) - Google Patents

미코박테리아 바케로부터의 치료제 및 hiv감염에 대한 그의 사용(therapeutic agent from mycobacterrium vaccae and its use against hiv infection)

Info

Publication number
KR950703360A
KR950703360A KR1019950701002A KR19950701002A KR950703360A KR 950703360 A KR950703360 A KR 950703360A KR 1019950701002 A KR1019950701002 A KR 1019950701002A KR 19950701002 A KR19950701002 A KR 19950701002A KR 950703360 A KR950703360 A KR 950703360A
Authority
KR
South Korea
Prior art keywords
mycobacterrium
vaccae
hiv infection
against hiv
use against
Prior art date
Application number
KR1019950701002A
Other languages
English (en)
Other versions
KR100272743B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR950703360A publication Critical patent/KR950703360A/ko
Application granted granted Critical
Publication of KR100272743B1 publication Critical patent/KR100272743B1/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/04Mycobacterium, e.g. Mycobacterium tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1019950701002A 1992-09-14 1993-03-05 Hiv 감염의 치료에 유용한 미코박테리움 바케로부터의 항원물질 KR100272743B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9219425.7 1992-09-14
GB929219425A GB9219425D0 (en) 1992-09-14 1992-09-14 Therapeutic agent and its use
PCT/GB1993/000463 WO1994006466A1 (en) 1992-09-14 1993-03-05 Therapeutic agent from mycobacterium vaccae and its use against hiv infection

Publications (2)

Publication Number Publication Date
KR950703360A true KR950703360A (ko) 1995-09-20
KR100272743B1 KR100272743B1 (ko) 2000-11-15

Family

ID=10721884

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950701002A KR100272743B1 (ko) 1992-09-14 1993-03-05 Hiv 감염의 치료에 유용한 미코박테리움 바케로부터의 항원물질

Country Status (18)

Country Link
EP (1) EP0661998B1 (ko)
JP (1) JPH06100457A (ko)
KR (1) KR100272743B1 (ko)
CN (1) CN1060937C (ko)
AP (1) AP510A (ko)
AT (1) ATE173633T1 (ko)
AU (1) AU683835B2 (ko)
BR (1) BR9303762A (ko)
CA (1) CA2105646A1 (ko)
DE (1) DE69322280T2 (ko)
DK (1) DK0661998T3 (ko)
ES (1) ES2125331T3 (ko)
GB (1) GB9219425D0 (ko)
HK (1) HK1011289A1 (ko)
RU (1) RU2106878C1 (ko)
SG (1) SG72610A1 (ko)
WO (1) WO1994006466A1 (ko)
ZA (1) ZA935575B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en) 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6878377B2 (en) 1996-12-18 2005-04-12 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
DK0951289T3 (da) * 1996-12-18 2006-03-13 Stanford Rook Ltd Anvendelse af Mycobacterium vaccae til behandling af kronisk træthedssyndrom
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
GB9903539D0 (en) 1999-02-16 1999-04-07 Stanford Rook Ltd Therapy using M.Vaccae
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
CA2472481A1 (en) * 2001-01-17 2002-07-25 Bakulesh Mafatlal Khamar Use of mycobacterium w for the treatment of human immunodeficiency virus (hiv) disease infection
WO2002056898A2 (en) * 2001-01-17 2002-07-25 Mafatlal Khamar Bakulesh Immunomodulator for the management of human immunodeficiency virus (hiv) disease/infection
WO2003063896A1 (en) * 2002-01-29 2003-08-07 Modi, Rajiv, Indravadan Process of preparing a pharmaceutical composition for immunity against tuberculosis in hiv positive individuals
BR0307262A (pt) * 2002-01-29 2006-12-19 Bakulesh Mafatlal Khamar método de prover profilaxia para tuberculose em indivìduos hiv positivos
WO2003075825A2 (en) * 2002-03-08 2003-09-18 Modi, Rajiv, Indravadan The method of treating tuberculosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3728367C1 (de) * 1987-08-25 1988-09-01 Burkhard Steglich Mittel zur Immunisierung des menschlichen Koerpers bei HIV-Infektionen
GB8917256D0 (en) * 1989-07-28 1989-09-13 Univ London Biological preparation and its use

Also Published As

Publication number Publication date
ZA935575B (en) 1994-03-01
CA2105646A1 (en) 1994-03-15
ES2125331T3 (es) 1999-03-01
JPH06100457A (ja) 1994-04-12
BR9303762A (pt) 1994-03-22
DK0661998T3 (da) 1999-08-09
CN1060937C (zh) 2001-01-24
DE69322280D1 (de) 1999-01-07
AU3642093A (en) 1994-04-12
RU2106878C1 (ru) 1998-03-20
EP0661998B1 (en) 1998-11-25
ATE173633T1 (de) 1998-12-15
CN1089478A (zh) 1994-07-20
AU683835B2 (en) 1997-11-27
AP510A (en) 1996-07-23
SG72610A1 (en) 2001-07-24
DE69322280T2 (de) 1999-04-22
AP9300555A0 (en) 1993-10-31
HK1011289A1 (en) 1999-07-09
WO1994006466A1 (en) 1994-03-31
KR100272743B1 (ko) 2000-11-15
EP0661998A1 (en) 1995-07-12
GB9219425D0 (en) 1992-10-28

Similar Documents

Publication Publication Date Title
EP0831873A4 (en) COMBINATORY THERAPY FOR THE TREATMENT OF HIV AND OTHER VIRAL INFECTIONS
DE69302257D1 (de) Pilzhemmendes und hautheilungsförderndes Mittel
NO964527L (no) Blandinger omfattende DNA-ödeleggende midler og P53
BR9303822A (pt) Dispositivo medico
DE69428093D1 (de) Patientenpflegevorrichtung
NO963508D0 (no) Ureasebasert vaksine og behandling av Heliobacter infeksjon
MX9101787A (es) Formulaciones,metodos y dispositivos anticonceptivos transdermicos
KR950703360A (ko) 미코박테리아 바케로부터의 치료제 및 hiv감염에 대한 그의 사용(therapeutic agent from mycobacterrium vaccae and its use against hiv infection)
ZA90245B (en) Treatment of diseases associated with hiv infections
KR880005157A (ko) 아크릴계 공중합체 및 피부보호제
FI965204A0 (fi) Bromelaiinin lääkekäyttö
TR24895A (tr) PIRIMIDIN TüREVLERI,BUNLARIN ISTIHSAL EDILMESI VE KULLANILMASI
PT983271E (pt) Hemissulfato carbociclico nucleosidico e a sua utilizacao no tratamento de infeccoes virais
MX9205892A (es) Agentes colinergicos de oxima y amina de azabiciclo y metodos de tratamiento.
DE69021304D1 (de) Vorbeugendes und therapeutisches Mittel gegen Hepatitis.
DE59306085D1 (de) Haar- und körperbehandlungsmittel
DE68906245D1 (de) Therapeutisches mittel gegen aids.
IT1239064B (it) Uso terapeutico del dipiridamolo
DE69112921D1 (de) Hygiene- und Behandlungsvorrichtung.
FI963263A (fi) Bromelaiinin lääkinnällinen käyttö
FI965196A0 (fi) HIV-infektion yhdistelmähoito
KR930008276U (ko) 일회용 무통 주사기
EP0490250A3 (en) Use of interferon and an antimalarial agent for the treatment of malarial infections
EP0655919A4 (en) TREATMENT OF VIRAL INFECTIONS IN MAN.
NO953003D0 (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee